Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer gene therapy clinical trials: lessons for the future.

Literature DB >> 11720424

Cancer gene therapy clinical trials: lessons for the future.

E Galanis¹, S Russell.

Abstract

Entities: Disease

Mesh：

Year: 2001 PMID： 11720424 PMCID： PMC2363959 DOI： 10.1054/bjoc.2001.2129

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

× No keyword cloud information.

37 in total

1. Gene therapy death prompts review of adenovirus vector.

Authors: E Marshall
Journal: Science Date: 1999-12-17 Impact factor: 47.728

Review 2. Immunotherapy of renal cell carcinoma by intratumoral administration of an IL-2 cDNA/DMRIE/DOPE lipid complex.

Authors: G A Daniels; E Galanis
Journal: Curr Opin Mol Ther Date: 2001-02

3. a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.

Authors: F R Khuri; J Nemunaitis; I Ganly; J Arseneau; I F Tannock; L Romel; M Gore; J Ironside; R H MacDougall; C Heise; B Randlev; A M Gillenwater; P Bruso; S B Kaye; W K Hong; D H Kirn
Journal: Nat Med Date: 2000-08 Impact factor: 53.440

4. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

Authors: N G Rainov
Journal: Hum Gene Ther Date: 2000-11-20 Impact factor: 5.695

Review 5. Gene therapy: a molecular approach to cancer treatment.

Authors: P Anklesaria
Journal: Curr Opin Mol Ther Date: 2000-08

6. Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience.

Authors: E Galanis; E M Hersh; A T Stopeck; R Gonzalez; P Burch; C Spier; E T Akporiaye; J J Rinehart; J Edmonson; R E Sobol; C Forscher; V K Sondak; B D Lewis; E C Unger; M O'Driscoll; L Selk; J Rubin
Journal: J Clin Oncol Date: 1999-10 Impact factor: 44.544

7. Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study.

Authors: M Schuler; R Herrmann; J L De Greve; A K Stewart; U Gatzemeier; D J Stewart; L Laufman; R Gralla; J Kuball; R Buhl; C P Heussel; F Kommoss; A P Perruchoud; F A Shepherd; M A Fritz; J A Horowitz; C Huber; C Rochlitz
Journal: J Clin Oncol Date: 2001-03-15 Impact factor: 44.544

8. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

Authors: M Cavazzana-Calvo; S Hacein-Bey; G de Saint Basile; F Gross; E Yvon; P Nusbaum; F Selz; C Hue; S Certain; J L Casanova; P Bousso; F L Deist; A Fischer
Journal: Science Date: 2000-04-28 Impact factor: 47.728

Review 9. Ad5CMVp53 gene therapy for locally advanced prostate cancer--where do we stand?

Authors: P Sweeney; L L Pisters
Journal: World J Urol Date: 2000-04 Impact factor: 4.226

10. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.

Authors: J M Markert; M D Medlock; S D Rabkin; G Y Gillespie; T Todo; W D Hunter; C A Palmer; F Feigenbaum; C Tornatore; F Tufaro; R L Martuza
Journal: Gene Ther Date: 2000-05 Impact factor: 5.250

8 in total

1. Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and in vivo.

Authors: Laura Masuelli; Fabrizio Pantanella; Giuseppe La Regina; Monica Benvenuto; Massimo Fantini; Rosanna Mattera; Enrica Di Stefano; Maurizio Mattei; Romano Silvestri; Serena Schippa; Vittorio Manzari; Andrea Modesti; Roberto Bei
Journal: Tumour Biol Date: 2015-10-13

Review 2. DNA-based therapeutics and DNA delivery systems: a comprehensive review.

Authors: Siddhesh D Patil; David G Rhodes; Diane J Burgess
Journal: AAPS J Date: 2005-04-08 Impact factor: 4.009

3. Transferrin-associated lipoplexes as gene delivery systems: relevance of mode of preparation and biophysical properties.

Authors: Nuno Penacho; Ana Filipe; Sérgio Simões; Maria C Pedroso de Lima
Journal: J Membr Biol Date: 2008-02-21 Impact factor: 1.843

Review 7. The Potential Protective Effects of Polyphenols in Asbestos-Mediated Inflammation and Carcinogenesis of Mesothelium.

Authors: Monica Benvenuto; Rosanna Mattera; Gloria Taffera; Maria Gabriella Giganti; Paolo Lido; Laura Masuelli; Andrea Modesti; Roberto Bei
Journal: Nutrients Date: 2016-05-09 Impact factor: 5.717

Review 8. RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs.

Authors: Sarah Bajan; Gyorgy Hutvagner
Journal: Cells Date: 2020-01-07 Impact factor: 6.600